New pill trial aims to shrink painful vascular growths
Disease control
Not yet recruiting
This study is testing whether a daily pill called KP-001 can safely shrink abnormal blood or lymph vessel growths and ease related symptoms like pain. It will involve about 150 patients, aged 2 and older, who have these growths and cannot be easily treated with surgery. For the f…
Phase: PHASE3 • Sponsor: Kaken Pharmaceutical • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC